_________________
Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934
Date of report (date of earliest event reported): March 4, 2004
ALARIS MEDICAL SYSTEMS, INC. | ||
(Exact name of registrant as specified in its charter) | ||
Delaware | 1-10207 | 13-3492624 |
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
incorporation or organization) | Identification Number) | |
|
||
10221 Wateridge Circle San Diego, CA 92121-1579 |
||
(Address, including zip code, of registrants principal executive offices) | ||
|
||
(858) 458-7000 | ||
Registrants telephone number, including area code |
The following information is being furnished under Item 12, Results of Operations and Financial Condition. Such information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934: |
On March 4, 2004, ALARIS Medical Systems, Inc. issued the press release attached as Exhibit 99.1, reporting its results for the year ended December 31, 2003. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
ALARIS MEDICAL SYSTEMS, INC. |
Date: March 4, 2004 |
By: /s/ DAVID L. SCHLOTTERBECK David L. Schlotterbeck President and Chief Executive Officer |
Exhibit
99.1 | Press release of ALARIS Medical Systems, Inc., dated March 4, 2004, reporting results for the year ended December 31, 2003. |